A modular and streamlined synthetic platform for diverse polyheterocyclic libraries. KU Leuven
Drug discovery is a lengthy, expensive, difficult, and inefficient process with quite a low rate of new therapeutic discoveries from existing molecules or new molecular entities. These projects generally start with a high-throughput screening campaign of commercially available compound libraries
against the target of interest. However in recent years, it became clear that current combinatorial libraries are not enough. As a mission of ...